Drug class
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor
Mechanism of action
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors [MoA]
General use cases
- Anemia
- anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months
- anemia due to chronic kidney disease in adults who have been receiving dialysis for at least four months
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
